Perrigo to acquire consumer self-care company HRA Pharma for about $2.1 billion in cash

Perrigo Co. Plc said Wednesday it has signed a binding offer to acquire Héra SAS, or HRA, a global self-care company, from funds affiliated with private-equity firm Astorg and Goldman Sachs Asset Management for about $2.1 billion in cash. HRA is an over-the-counter products company with with three self-care brands in blister care with Compeed, in women's health with ellaOne and in scar care with Mederma. The deal is expected to "complete Perrigo's transformation to a global leader in...